Corey N. Fishman - 06 Aug 2024 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role: Chief Executive Officer, Director
Signature: /s/ Corey N. Fishman
Issuer symbol: ITRM
Transactions as of: 06 Aug 2024
Net transactions value: $0
Form type: 4
Filing time: 12 Aug 2024, 09:00:04 UTC
Previous filing: 20 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITRM	Ordinary Shares	Options Exercise		+82,613	+152%		137,062	06 Aug 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITRM	Subscription Rights (right to buy)	Options Exercise	$0	-165,226	-100%	$0.000000^*	0	06 Aug 2024	Units		$0.6100	Direct	F1, F2
transaction	ITRM	Warrants (right to buy)	Options Exercise		+82,613			82,613	06 Aug 2024	Ordinary Shares	41,306	$1.21	Direct	F1
transaction	ITRM	Warrants (right to buy)	Options Exercise		+82,613			82,613	06 Aug 2024	Ordinary Shares	82,613	$1.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities were purchased in the Issuer's rights offering (the "Offering") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 82,613 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance ("1-year warrants"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance ("5-year warrants").
F2	The Reporting Person validly exercised 165,226 subscription rights to acquire 82,613 units composed of (i) 82,613 ordinary shares, (ii) 82,613 1-year warrants and (iii) 82,613 5-year warrants.

Content

The reported securities were purchased in the Issuer's rights offering (the "Offering") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 82,613 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance ("1-year warrants"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance ("5-year warrants").

The Reporting Person validly exercised 165,226 subscription rights to acquire 82,613 units composed of (i) 82,613 ordinary shares, (ii) 82,613 1-year warrants and (iii) 82,613 5-year warrants.